Title:
PHARMACEUTICAL COMPOSITION IN SINGLE DOSAGE FORM FOR TREATING OR PREVENTING HYPERTENSION AND HYPERCHOLESTEROLEMIA
Document Type and Number:
WIPO Patent Application WO/2022/045759
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composite formulation containing a composition comprising rosuvastatin or a salt thereof and ezetimibe or a salt thereof, wherein the pharmaceutical composition may further comprise olmesartan medoxomil and amlodipine or a salt thereof. According to the present invention, the composition containing drugs is mixed and formulated into a single form to minimize the problems related to the drug dissolution and absorption due to interaction between the drugs and to secure stability and uniform dissolution rates of drugs, whereby a biologically equivalent formulation can be obtained when compared to conventional single formulations.
More Like This:
Inventors:
PARK JUNG HYUN (KR)
KIM JI YEON (KR)
KIM BO HOON (KR)
KIM GWAN YOUNG (KR)
LEE KYUNGMIN (KR)
LEE JAE-HYEOP (KR)
KIM JI YEON (KR)
KIM BO HOON (KR)
KIM GWAN YOUNG (KR)
LEE KYUNGMIN (KR)
LEE JAE-HYEOP (KR)
Application Number:
PCT/KR2021/011350
Publication Date:
March 03, 2022
Filing Date:
August 25, 2021
Export Citation:
Assignee:
DAE WOONG PHARMA (KR)
International Classes:
A61K9/20; A61K9/24; A61K9/28; A61K9/50; A61K31/397; A61K31/4164; A61K31/4422; A61K31/505
Domestic Patent References:
| WO2009024889A2 | 2009-02-26 |
Foreign References:
| KR20160000762A | 2016-01-05 | |||
| KR20160105044A | 2016-09-06 | |||
| KR20150079373A | 2015-07-08 | |||
| KR20170007695A | 2017-01-19 | |||
| KR20090065510A | 2009-06-22 |
Attorney, Agent or Firm:
DANA PATENT LAW FIRM (KR)
Download PDF: